These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 33954112)
1. Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma. Qiu H; Tian W; He Y; Li J; He C; Li Y; Liu N; Li J Front Oncol; 2021; 11():654350. PubMed ID: 33954112 [TBL] [Abstract][Full Text] [Related]
2. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma. Xu S; Wang Z; Ye J; Mei S; Zhang J Front Oncol; 2021; 11():729103. PubMed ID: 34568059 [TBL] [Abstract][Full Text] [Related]
3. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma. Hao YP; Wang WY; Qiao Q; Li G Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884 [TBL] [Abstract][Full Text] [Related]
4. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
5. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma. Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A Front Genet; 2021; 12():718717. PubMed ID: 34925438 [No Abstract] [Full Text] [Related]
6. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma. Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773 [TBL] [Abstract][Full Text] [Related]
7. Screening TCGA database for prognostic genes in lower grade glioma microenvironment. Ni J; Liu S; Qi F; Li X; Yu S; Feng J; Zheng Y Ann Transl Med; 2020 Mar; 8(5):209. PubMed ID: 32309356 [TBL] [Abstract][Full Text] [Related]
8. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma. Ma W; Mei P World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196 [TBL] [Abstract][Full Text] [Related]
9. CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment. Wang F; Tao Z; Tian Z; Jin J; Dong J; Dai Y; Yu W; Tang B; Hu S Front Genet; 2022; 13():874896. PubMed ID: 35865011 [No Abstract] [Full Text] [Related]
10. The N6-Methylandenosine-Related Gene Jiang X; Shi Y; Chen X; Xu H; Huang X; Li L; Pu J Front Mol Biosci; 2022; 9():773662. PubMed ID: 35309512 [TBL] [Abstract][Full Text] [Related]
11. Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma. Chai RC; Wang N; Chang YZ; Zhang KN; Li JJ; Niu JJ; Wu F; Liu YQ; Wang YZ Cancer Cell Int; 2019; 19():155. PubMed ID: 31171919 [TBL] [Abstract][Full Text] [Related]
12. DNMT3A promotes glioma growth and malignancy via TNF-α/NF-κB signaling pathway. Su X; Liu J; Tu Z; Ji Q; Li J; Liu F Transl Cancer Res; 2024 Apr; 13(4):1786-1806. PubMed ID: 38737693 [TBL] [Abstract][Full Text] [Related]
13. PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma. Li P; Chen F; Yao C; Zhu K; Zhang B; Zheng Z Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741647 [TBL] [Abstract][Full Text] [Related]
14. FAM109B plays a tumorigenic role in low-grade gliomas and is associated with tumor-associated macrophages (TAMs). Zhang Z; Xiao Y; Zhao S; Liu J; Zeng J; Xiao F; Liao B; Shan X; Zhu H; Guo H J Transl Med; 2024 Sep; 22(1):833. PubMed ID: 39256832 [TBL] [Abstract][Full Text] [Related]
15. ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma. Zhang C; Wang L; Liu H; Deng G; Xu P; Tan Y; Xu Y; Liu B; Chen Q; Tian D J Cancer; 2021; 12(10):2912-2920. PubMed ID: 33854592 [No Abstract] [Full Text] [Related]
16. CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma. Wang D; Sun H; Li X; Wang G; Yan G; Ren H; Hou B Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908101 [TBL] [Abstract][Full Text] [Related]
17. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
18. A Prognostic Microenvironment-Related Immune Signature Qiu H; Li Y; Cheng S; Li J; He C; Li J Front Oncol; 2020; 10():580263. PubMed ID: 33425732 [TBL] [Abstract][Full Text] [Related]
19. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset. Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma. Zhang Q; Liu XJ; Li Y; Ying XW; Chen L Technol Cancer Res Treat; 2021; 20():15330338211011966. PubMed ID: 34159865 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]